Repligen Corporation (RGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript

Core Insights - The company has experienced strong performance across all business segments and geographies in the third quarter and the first three quarters of the year [2] - The organic growth rate for the quarter was 18%, with growth rates ranging from 14% to 18% over the last four quarters [3] Growth Factors - The outgrowth algorithm for the company is influenced by factors such as fluid management and strategic accounts, alongside traditional drivers like market expansion in China and new product modalities [1]